680 / 1173
1/03/2016
19
Bevacizumab
•
Chimeric monoclonal antibody that targets VEGF
Bevacizumab 5 mg/kg
Willett Nat Med 2004
Willett CG,J Clin Oncol 2005
Neo-adjuvant BV in rectal cancer
•
Landmark trial: Phase I study results in 6 LARC pts